{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T23:18:52Z","timestamp":1767568732111,"version":"3.48.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["11240017"],"award-info":[{"award-number":["11240017"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Reproductive Health Research Institute"}],"content-domain":{"domain":["rep.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,6]]},"abstract":"<jats:sec>\n                    <jats:title>In brief<\/jats:title>\n                    <jats:p>Progesterone supplementation reverses 83% of transcript changes in the secretory endometrium induced by postovulatory mifepristone, potentially mitigating its antiprogestogenic effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Mifepristone (RU486) antagonizes progesterone signaling in human endometrium interfering in the secretory phenotype after estradiol priming. The objective of the present study was to determine effect in the endometrial transcript profile of progesterone supplementation after the administration of 200 mg of the antiprogestin mifepristone 48 h after the LH peak (LH+2, LH+0 = LH peak). Endometrial samples were obtained on LH+7 after vaginal administration of micronized progesterone 200 mg\/day for 3 days in nine women of proven fertility, each one contributing with one cycle treated with progesterone and another with a placebo. In addition, endometrial samples were obtained in LH+7 from a subgroup of four women with no administration of mifepristone, with each one contributing with one cycle treated with vaginal progesterone supplementation or placebo as a reference. RNA-seq was used to identify transcripts significantly regulated under the administration of progesterone vs placebo with or without postovulatory mifepristone. We observed that 713 transcripts changed significantly in the endometrium under mifepristone after progesterone supplementation in group A. Of these, progesterone reversed approximately 83% of the transcripts affected by mifepristone in the secretory endometrium. Bioinformatic analyses revealed that these transcripts were enriched in genes associated with mitochondrial function, particularly oxidative phosphorylation. In addition, NR2C2 and DLX1 were identified as potential transcription factors that may mediate the effects of progesterone in the endometrium. We conclude that progesterone supplementation after postovulatory mifepristone administration can reverse the antiprogestogenic effects for most of the affected endometrial transcripts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/rep-24-0372","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T09:09:21Z","timestamp":1741252161000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-11","source":"Crossref","is-referenced-by-count":0,"title":["Progesterone supplementation after postovulatory mifepristone reduce changes in human endometrial gene expression"],"prefix":"10.1093","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0742-8395","authenticated-orcid":true,"given":"Alejandro","family":"Tapia-Pizarro","sequence":"first","affiliation":[{"name":"Institute of Mother and Child Research, Faculty of Medicine, Universidad de Chile, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8919-833X","authenticated-orcid":true,"given":"Nicol\u00e1s","family":"Santander","sequence":"additional","affiliation":[{"name":"Instituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abril","family":"Salinas","sequence":"additional","affiliation":[{"name":"Institute of Mother and Child Research, Faculty of Medicine, Universidad de Chile, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Torres","sequence":"additional","affiliation":[{"name":"Institute of Mother and Child Research, Faculty of Medicine, Universidad de Chile, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Vega","sequence":"additional","affiliation":[{"name":"Institute of Mother and Child Research, Faculty of Medicine, Universidad de Chile, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"del Rio","sequence":"additional","affiliation":[{"name":"Reproductive Health Research Institute, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Vigil","sequence":"additional","affiliation":[{"name":"Reproductive Health Research Institute, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"bib1","series-title":"J Clin Endocrinol Metab","first-page":"5071","article-title":"The glucocorticoid receptor is specifically expressed in the stromal compartment of the human endometrium","volume":"86","author":"Bamberger AM","year":"2001","unstructured":"Bamberger AM\n, \nMilde-Langosch K\n, \nLoning T\n, et al.\n 2001 The glucocorticoid receptor is specifically expressed in the stromal compartment of the human endometrium. J Clin Endocrinol Metab 86 5071\u20135074. (https:\/\/doi.org\/10.1210\/jcem.86.10.8101)"},{"key":"bib2","series-title":"J Clin Endocrinol Metab","first-page":"25","article-title":"The new steroid analog RU 486 inhibits glucocorticoid action in man","volume":"59","author":"Bertagna X","year":"1984","unstructured":"Bertagna X\n, \nBertagna C\n, \nLuton JP\n, et al.\n 1984 The new steroid analog RU 486 inhibits glucocorticoid action in man. J Clin Endocrinol Metab 59 25\u201328. (https:\/\/doi.org\/10.1210\/jcem-59-1-25)"},{"key":"bib3","series-title":"Reprod Biol Endocrinol","first-page":"S2","article-title":"Basic and applied biology of the primate reproductive tract--a symposium in honor of the career of Dr Robert M Brenner: introduction and overview","volume":"4","author":"Brenner RM","year":"2006","unstructured":"Brenner RM\n\n 2006 Basic and applied biology of the primate reproductive tract--a symposium in honor of the career of Dr Robert M Brenner: introduction and overview. Reprod Biol Endocrinol 4 (Supplement 1) S2. (https:\/\/doi.org\/10.1186\/1477-7827-4-s1-s2)"},{"key":"bib4","series-title":"Fertil Steril","first-page":"1046","article-title":"Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation","volume":"67","author":"Cameron ST","year":"1997","unstructured":"Cameron ST\n, \nCritchley HO\n, \nBuckley CH\n, et al.\n 1997 Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation. Fertil Steril 67 1046\u20131053. (https:\/\/doi.org\/10.1016\/s0015-0282(97)81437-9)"},{"key":"bib5","series-title":"Hum Reprod Update","first-page":"293","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet N","year":"2005","unstructured":"Chabbert-Buffet N\n, \nMeduri G\n, \nBouchard P\n, et al.\n 2005 Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Hum Reprod Update 11 293\u2013307. (https:\/\/doi.org\/10.1093\/humupd\/dmi002)"},{"key":"bib6","series-title":"Oncogene","first-page":"1404","article-title":"DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-\u03b2\/SMAD4 signaling","volume":"36","author":"Chan DW","year":"2017","unstructured":"Chan DW\n, \nHui WW\n, \nWang JJ\n, et al.\n 2017 DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-\u03b2\/SMAD4 signaling. Oncogene 36 1404\u20131416. (https:\/\/doi.org\/10.1038\/onc.2016.307)"},{"key":"bib7","series-title":"Proc Natl Acad Sci U S A","first-page":"6040","article-title":"Human and rat TR4 orphan receptors specify a subclass of the steroid receptor superfamily","volume":"91","author":"Chang C","year":"1994","unstructured":"Chang C\n, \nDa Silva SL\n, \nIdeta R\n, et al.\n 1994 Human and rat TR4 orphan receptors specify a subclass of the steroid receptor superfamily. Proc Natl Acad Sci U S A 91 6040\u20136044. (https:\/\/doi.org\/10.1073\/pnas.91.13.6040)"},{"key":"bib8","series-title":"J Biol Chem","first-page":"12335","article-title":"Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1","volume":"278","author":"Chauchereau A","year":"2003","unstructured":"Chauchereau A\n, \nAmazit L\n, \nQuesne M\n, et al.\n 2003 Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. J Biol Chem 278 12335\u201312343. (https:\/\/doi.org\/10.1074\/jbc.m207148200)"},{"key":"bib9","series-title":"Hum Reprod","first-page":"1968","article-title":"Mifepristone acts as progesterone antagonist of non-genomic responses but inhibits phytohemagglutinin-induced proliferation in human T cells","volume":"24","author":"Chien CH","year":"2009","unstructured":"Chien CH\n, \nLai JN\n, \nLiao CF\n, et al.\n 2009 Mifepristone acts as progesterone antagonist of non-genomic responses but inhibits phytohemagglutinin-induced proliferation in human T cells. Hum Reprod 24 1968\u20131975. (https:\/\/doi.org\/10.1093\/humrep\/dep099)"},{"key":"bib10","series-title":"Reproduction","first-page":"331","article-title":"Effect of single post-ovulatory administration of mifepristone (RU486) on transcript profile during the receptive period in human endometrium","volume":"151","author":"Cuevas CA","year":"2016","unstructured":"Cuevas CA\n, \nTapia-Pizarro A\n, \nSalvatierra AM\n, et al.\n 2016 Effect of single post-ovulatory administration of mifepristone (RU486) on transcript profile during the receptive period in human endometrium. Reproduction 151 331\u2013349. (https:\/\/doi.org\/10.1530\/rep-15-0458)"},{"key":"bib11","series-title":"J Mol Endocrinol","first-page":"R47","article-title":"Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology","volume":"53","author":"Dasgupta S","year":"2014","unstructured":"Dasgupta S\n & \nO'Malley BW\n\n 2014 Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology. J Mol Endocrinol 53 R47\u2013R59. (https:\/\/doi.org\/10.1530\/jme-14-0080)"},{"key":"bib12","series-title":"Sci Rep","first-page":"1559","article-title":"Benchmarking of RNA-sequencing analysis workflows using whole-transcriptome RT-qPCR expression data","volume":"7","author":"Everaert C","year":"2017","unstructured":"Everaert C\n, \nLuypaert M\n, \nMaag JLV\n, et al.\n 2017 Benchmarking of RNA-sequencing analysis workflows using whole-transcriptome RT-qPCR expression data. Sci Rep 7 1559. (https:\/\/doi.org\/10.1038\/s41598-017-01617-3)"},{"key":"bib13","series-title":"Am J Clin Nutr","first-page":"884S","article-title":"Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis","volume":"93","author":"Fernandez-Marcos PJ","year":"2011","unstructured":"Fernandez-Marcos PJ\n & \nAuwerx J\n\n 2011 Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 93 884S\u2013890S. (https:\/\/doi.org\/10.3945\/ajcn.110.001917)"},{"key":"bib14","series-title":"BMC Evol Biol","first-page":"15","article-title":"Non-parsimonious evolution of hagfish Dlx genes","volume":"13","author":"Fujimoto S","year":"2013","unstructured":"Fujimoto S\n, \nOisi Y\n, \nKuraku S\n, et al.\n 2013 Non-parsimonious evolution of hagfish Dlx genes. BMC Evol Biol 13 15. (https:\/\/doi.org\/10.1186\/1471-2148-13-15)"},{"key":"bib15","series-title":"J Endocrinol","first-page":"357","article-title":"Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair","volume":"178","author":"Gellersen B","year":"2003","unstructured":"Gellersen B\n & \nBrosens J\n\n 2003 Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair. J Endocrinol 178 357\u2013372. (https:\/\/doi.org\/10.1677\/joe.0.1780357)"},{"key":"bib16","series-title":"Hum Reprod Update","first-page":"119","article-title":"Non-genomic progesterone actions in female reproduction","volume":"15","author":"Gellersen B","year":"2009","unstructured":"Gellersen B\n, \nFernandes MS\n & \nBrosens JJ\n\n 2009 Non-genomic progesterone actions in female reproduction. Hum Reprod Update 15 119\u2013138. (https:\/\/doi.org\/10.1093\/humupd\/dmn044)"},{"key":"bib17","series-title":"Hum Reprod","first-page":"1626","article-title":"The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2 alpha concentrations","volume":"9","author":"Gemzell-Danielsson K","year":"1994","unstructured":"Gemzell-Danielsson K\n & \nHamberg M\n\n 1994 The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2 alpha concentrations. Hum Reprod 9 1626\u20131630. (https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a138763)"},{"key":"bib18","series-title":"Hum Reprod","first-page":"870","article-title":"Early luteal phase treatment with mifepristone (RU 486) for fertility regulation","volume":"8","author":"Gemzell-Danielsson K","year":"1993","unstructured":"Gemzell-Danielsson K\n, \nSwahn ML\n, \nSvalander P\n, et al.\n 1993 Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Hum Reprod 8 870\u2013873. (https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a138157)"},{"key":"bib19","series-title":"Endocr Rev","first-page":"502","article-title":"Physiological action of progesterone in target tissues","volume":"18","author":"Graham JD","year":"1997","unstructured":"Graham JD\n & \nClarke CL\n\n 1997 Physiological action of progesterone in target tissues. Endocr Rev 18 502\u2013519. (https:\/\/doi.org\/10.1210\/edrv.18.4.0308)"},{"key":"bib20","series-title":"Hum Reprod","first-page":"1145","article-title":"Feasibility of administering mifepristone as a once a month contraceptive pill","volume":"16","author":"Hapangama DK","year":"2001","unstructured":"Hapangama DK\n, \nBrown A\n, \nGlasier AF\n, et al.\n 2001 Feasibility of administering mifepristone as a once a month contraceptive pill. Hum Reprod 16 1145\u20131150. (https:\/\/doi.org\/10.1093\/humrep\/16.6.1145)"},{"key":"bib21","series-title":"J Biol","first-page":"3","article-title":"Validation' in genome-scale research","volume":"8","author":"Hughes TR","year":"2009","unstructured":"Hughes TR\n\n 2009 Validation' in genome-scale research. J Biol 8 3. (https:\/\/doi.org\/10.1186\/jbiol104)"},{"key":"bib22","series-title":"J Cell Physiol","first-page":"779","article-title":"Dlx homeobox gene family expression in osteoclasts","volume":"223","author":"Lezot F","year":"2010","unstructured":"Lezot F\n, \nThomas BL\n, \nBlin-Wakkach C\n, et al.\n 2010 Dlx homeobox gene family expression in osteoclasts. J Cell Physiol 223 779\u2013787. (https:\/\/doi.org\/10.1002\/jcp.22095)"},{"key":"bib23","series-title":"Proc Natl Acad Sci U S A","first-page":"7940","article-title":"Coactivator\/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486","volume":"99","author":"Liu Z","year":"2002","unstructured":"Liu Z\n, \nAuboeuf D\n, \nWong J\n, et al.\n 2002 Coactivator\/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486. Proc Natl Acad Sci U S A 99 7940\u20137944. (https:\/\/doi.org\/10.1073\/pnas.122225699)"},{"key":"bib24","series-title":"J Clin Endocrinol Metab","first-page":"913","article-title":"The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study","volume":"77","author":"Maentausta O","year":"1993","unstructured":"Maentausta O\n, \nSvalander P\n, \nDanielsson KG\n, et al.\n 1993 The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study. J Clin Endocrinol Metab 77 913\u2013918. (https:\/\/doi.org\/10.1210\/jcem.77.4.8408465)"},{"key":"bib25","series-title":"Biochem Biophys Res Commun","first-page":"740","article-title":"Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA","volume":"143","author":"Misrahi M","year":"1987","unstructured":"Misrahi M\n, \nAtger M\n, \nd'Auriol L\n, et al.\n 1987 Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem Biophys Res Commun 143 740\u2013748. (https:\/\/doi.org\/10.1016\/0006-291x(87)91416-1)"},{"key":"bib26","series-title":"Am J Obstet Gynecol","first-page":"262","article-title":"Dating the endometrial biopsy","volume":"122","author":"Noyes RW","year":"1975","unstructured":"Noyes RW\n, \nHertig AT\n & \nRock J\n\n 1975 Dating the endometrial biopsy. Am J Obstet Gynecol 122 262\u2013263. (https:\/\/doi.org\/10.1016\/s0002-9378(16)33500-1)"},{"key":"bib27","series-title":"Biol Reprod","first-page":"163","article-title":"Molecular pathways of steroid receptor action","volume":"46","author":"O\u2019Malley BW","year":"1992","unstructured":"O\u2019Malley BW\n & \nTsai MJ\n\n 1992 Molecular pathways of steroid receptor action. Biol Reprod 46 163\u2013167. (https:\/\/doi.org\/10.1095\/biolreprod46.2.163)"},{"key":"bib28","series-title":"Development","article-title":"DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression","volume":"149","author":"Price JD","year":"2022","unstructured":"Price JD\n, \nLindtner S\n, \nYpsilanti A\n, et al.\n 2022 DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression. Development 149 dev199508. (https:\/\/doi.org\/10.1242\/dev.199508)"},{"key":"bib29","series-title":"Int J Dev Biol","first-page":"1729","article-title":"Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells","volume":"54","author":"Prigione A","year":"2010","unstructured":"Prigione A\n & \nAdjaye J\n\n 2010 Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells. Int J Dev Biol 54 1729\u20131741. (https:\/\/doi.org\/10.1387\/ijdb.103198ap)"},{"key":"bib30","series-title":"J Biol Chem","first-page":"14622","article-title":"Modulation of estrogen receptor-mediated transactivation by orphan receptor TR4 in MCF-7 cells","volume":"277","author":"Shyr CR","year":"2002","unstructured":"Shyr CR\n, \nHu YC\n, \nKim E\n, et al.\n 2002 Modulation of estrogen receptor-mediated transactivation by orphan receptor TR4 in MCF-7 cells. J Biol Chem 277 14622\u201314628. (https:\/\/doi.org\/10.1074\/jbc.m110051200)"},{"key":"bib31","series-title":"Contraception","first-page":"409","article-title":"Pharmacological properties of mifepristone: toxicology and safety in animal and human studies","volume":"68","author":"Sitruk-Ware R","year":"2003","unstructured":"Sitruk-Ware R\n & \nSpitz IM\n\n 2003 Pharmacological properties of mifepristone: toxicology and safety in animal and human studies. Contraception 68 409\u2013420. (https:\/\/doi.org\/10.1016\/s0010-7824(03)00171-9)"},{"key":"bib32","series-title":"Steroids","first-page":"981","article-title":"Progesterone antagonists and progesterone receptor modulators: an overview","volume":"68","author":"Spitz IM","year":"2003","unstructured":"Spitz IM\n\n 2003 Progesterone antagonists and progesterone receptor modulators: an overview. Steroids 68 981\u2013993. (https:\/\/doi.org\/10.1016\/j.steroids.2003.08.007)"},{"key":"bib33","series-title":"Hum Reprod","first-page":"402","article-title":"The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium","volume":"5","author":"Swahn ML","year":"1990","unstructured":"Swahn ML\n, \nBygdeman M\n, \nCekan S\n, et al.\n 1990 The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium. Hum Reprod 5 402\u2013408. (https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a137111)"},{"key":"bib34","series-title":"J Steroid Biochem Mol Biol","first-page":"32","article-title":"Steroid receptor coactivators as therapeutic targets in the female reproductive system","volume":"154","author":"Szwarc MM","year":"2015","unstructured":"Szwarc MM\n, \nLydon JP\n & \nO\u2019Malley BW\n\n 2015 Steroid receptor coactivators as therapeutic targets in the female reproductive system. J Steroid Biochem Mol Biol 154 32\u201338. (https:\/\/doi.org\/10.1016\/j.jsbmb.2015.06.010)"},{"key":"bib35","series-title":"Hum Reprod Update","first-page":"139","article-title":"Comparison between different routes of progesterone administration as luteal phase support in infertility treatments","volume":"6","author":"Tavaniotou A","year":"2000","unstructured":"Tavaniotou A\n, \nSmitz J\n, \nBourgain C\n, et al.\n 2000 Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update 6 139\u2013148. (https:\/\/doi.org\/10.1093\/humupd\/6.2.139)"},{"key":"bib36","series-title":"Annu Rev Biochem","first-page":"451","article-title":"Molecular mechanisms of action of steroid\/thyroid receptor superfamily members","volume":"63","author":"Tsai MJ","year":"1994","unstructured":"Tsai MJ\n & \nO'Malley BW\n\n 1994 Molecular mechanisms of action of steroid\/thyroid receptor superfamily members. Annu Rev Biochem 63 451\u2013486. (https:\/\/doi.org\/10.1146\/annurev.biochem.63.1.451)"},{"key":"bib37","series-title":"Cell Death Dis","first-page":"226","article-title":"Imbalance in mitochondrial dynamics induced by low PGC-1\u03b1 expression contributes to hepatocyte EMT and liver fibrosis","volume":"11","author":"Zhang L","year":"2020","unstructured":"Zhang L\n, \nZhang Y\n, \nChang X\n, et al.\n 2020 Imbalance in mitochondrial dynamics induced by low PGC-1\u03b1 expression contributes to hepatocyte EMT and liver fibrosis. Cell Death Dis 11 226. (https:\/\/doi.org\/10.1038\/s41419-020-2429-9)"}],"container-title":["Reproduction"],"original-title":[],"link":[{"URL":"https:\/\/rep.bioscientifica.com\/view\/journals\/rep\/169\/4\/REP-24-0372.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/rep.bioscientifica.com\/downloadpdf\/journals\/rep\/169\/4\/REP-24-0372.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rep.bioscientifica.com\/downloadpdf\/journals\/rep\/169\/4\/REP-24-0372.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T23:03:36Z","timestamp":1767567816000},"score":1,"resource":{"primary":{"URL":"https:\/\/rep.bioscientifica.com\/view\/journals\/rep\/169\/4\/REP-24-0372.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":37,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1530\/rep-24-0372","relation":{},"ISSN":["1470-1626","1741-7899"],"issn-type":[{"type":"print","value":"1470-1626"},{"type":"electronic","value":"1741-7899"}],"subject":[],"published":{"date-parts":[[2025,3,6]]}}}